CPTCF (Cytophage Technologies) Buyback Yield %: -813.61 (As of Jul. 03, 2026)


CPTCF Cytophage Technologies Ltd CPTCF
18 GF Score
Price $0.21
! 1 Warning Sign
View Full Analysis

What is Cytophage Technologies Buyback Yield %?

Cytophage Technologies CPTCF 18 Buyback Yield % is -813.61 as of Jul. 03, 2026. GuruFocus rates CPTCF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 744 Biotechnology companies, Cytophage Technologies ranks worse than 99.46% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cytophage Technologies's current buyback yield was -813.61%.

Cytophage Technologies Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Buyback Yield % Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 0.00 -14.24

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -14.78 -10.05 -27.09

CPTCF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Cytophage Technologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Buyback Yield % falls into.


CPTCF
18GF Score
Cytophage Technologies Ltd CPTCF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytophage Technologies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cytophage Technologies's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.993) / 13.997258
=-14.24%

Cytophage Technologies's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1.993) / 13.997258
=-14.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -813.61 mean?
Cytophage Technologies (CPTCF) has a Buyback Yield % of -813.61 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cytophage Technologies and its competitors. According to the industry distribution chart, Cytophage Technologies ranks #740 out of 744 companies in the Biotechnology industry, placing it in the top 99.5%.
Is Cytophage Technologies' Buyback Yield % too high?
Cytophage Technologies' current Buyback Yield % is -813.61. Based on the distribution chart, Cytophage Technologies ranks #740 out of 744 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Cytophage Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cytophage Technologies' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cytophage Technologies ranks #740 out of 744 companies for Buyback Yield %. This places Cytophage Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Buyback Yield % is -813.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (CPTCF) has a current Buyback Yield % of -813.61. The current Buyback Yield % is -813.61. Cytophage Technologies' overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cytophage Technologies (CPTCF), the current Buyback Yield % is -813.61 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Other Exchanges CYTO.H:Canada
Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.
18GF Score

Get the complete analysis for CPTCF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price